Fabry Disesase clinical trials at University of California Health

1 in progress, 0 open to eligible people

Showing trials for

  • HM15421/GC1134A in Patients with Fabry Disease

    Sorry, not yet accepting patients

    This Phase 1/2 first-in-human (FIH) study is designed to evaluate the safety, tolerability, pharmacokinetics (PK), and efficacy of HM15421 in patients with FD.

    at UCLA

Last updated: